Wed, November 7, 2012
Tue, November 6, 2012
Mon, November 5, 2012
Sat, November 3, 2012
Fri, November 2, 2012
Thu, November 1, 2012
Wed, October 31, 2012
Tue, October 30, 2012
Mon, October 29, 2012
Sun, October 28, 2012
Fri, October 26, 2012
Thu, October 25, 2012
Wed, October 24, 2012
Tue, October 23, 2012
Mon, October 22, 2012
Sun, October 21, 2012
Sat, October 20, 2012
Fri, October 19, 2012
Thu, October 18, 2012
Wed, October 17, 2012
Tue, October 16, 2012
Mon, October 15, 2012
Sun, October 14, 2012
Fri, October 12, 2012

Cambrex to Announce Third Quarter 2012 Financial Results on October 31, 2012


  Copy link into your clipboard //health-fitness.news-articles.net/content/2012/ .. r-2012-financial-results-on-october-31-2012.html
  Print publication without navigation Published in Health and Fitness on by Market Wire


Cambrex to Announce Third Quarter 2012 Financial Results on October 31,... -- EAST RUTHERFORD, N.J., Oct. 26, 2012 /PRNewswire/ --

EAST RUTHERFORD, N.J., Oct. 26, 2012 /PRNewswire/ -- Cambrex Corporation (NYSE: [ CBM ]) announced that third quarter 2012 financial results will be released on Wednesday, October 31, 2012 after the market closes.

The Company will host a conference call to discuss the financial results.

   Third Quarter 2012 Earnings Conference Call


When:  

Thursday, November 1, 2012 at 8:30 a.m. Eastern Time



Dial-in:  

1-888-430-8705 for U.S.


1-719-325-2455 for International


Passcode:  1704787



Dial-in Replay:

1-888-203-1112 for U.S.


1-719-457-0820 for International


Passcode: 1704787


Available through Thursday, November 8, 2012



Webcast:

[ www.cambrex.com ]   

About Cambrex

Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.  We offer Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Our development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products.  For more information, please visit [ www.cambrex.com ].  

SOURCE Cambrex Corporation



RELATED LINKS
[ http://www.cambrex.com ]

Publication Contributing Sources

Publication Sponsors
[ Last Sunday ] - Oceanside Rental Gear